latest news releases from the newsroom
Pharsight and CRI Worldwide Establish Alliance
MOUNTAIN VIEW, Calif., and CLEMENTON, N.J., July 22, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, and CRI Worldwide, a leading provider of clinical research services to the global pharmaceutical and biotech industries, today announced that they have formed an alliance to offer combined services including trial design, simulation, execution, analysis and reporting. The alliance provides a broader solution to customers and addresses the growing need for drug development companies to improve the efficiency in their performance and analysis of clinical trials.
Wilshire Bancorp, Inc.
Wilshire Bancorp Posts Net Income of $7.4 Million, or $0.25 Per Diluted Share, in the Second Quarter 2008
LOS ANGELES, July 22, 2008 (PRIME NEWSWIRE) -- Wilshire Bancorp, Inc. (Nasdaq:WIBC), the holding company for Wilshire State Bank, reported diluted earnings per share of $0.25 for the second quarter 2008, compared with $0.24 in the first quarter 2008 and $0.25 in the second quarter 2007. Net income was $7.43 million, compared with $7.05 million in prior quarter and $7.35 million in the second quarter 2007.
Chart Industries, Inc.
Chart Industries Announces Second Quarter 2008 Conference Call
CLEVELAND, July 22, 2008 (PRIME NEWSWIRE) -- Chart Industries, Inc. (Nasdaq:GTLS) has scheduled a conference call for Thursday, July 31, 2008, at 10:30 a.m. ET to discuss its second quarter 2008 financial results. Chart plans to issue its earnings release on Thursday, July 31, prior to the call.
Pharsight to Present On Modeling and Simulation At Quebec CPT World Congress
MOUNTAIN VIEW, Calif., July 22, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that two members of its scientific consulting staff have been invited to speak to members of the biotechnology and pharmaceutical industries attending the 9th World Congress on Clinical Pharmacology and Therapeutics (CPT). The CPT Congress will be held at the Quebec City Convention Center in Quebec City, Canada, from July 27-August 1, 2008.
CombiMatrix's Newly Updated Autism Test Gains Market Attention
MUKILTEO, Wash., July 22, 2008 (PRIME NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has launched an updated version of its ATScan(tm) test for pre-disposition screening for autism, through its wholly owned subsidiary CombiMatrix Molecular Diagnostics (CMDX). The ATScan test has been updated to encompass recent discoveries published in the journal, Science, which confirm the role of several new genomic imbalances in the etiology of Autism Spectrum Disorder (ASD) (Morrow et al., Science, 11 July 2008, Vol 321).